Normoferremia in Patients with Acute Bacterial Infections-A Hitherto Unexplored Field of the Dichotomy between CRP and Ferritin Expression in Patients with Hyper Inflammation and Failure to Increase Ferritin.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jul 2023
Historique:
received: 08 06 2023
revised: 06 07 2023
accepted: 07 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Ferritin is an acute phase response protein, which may not rise as expected in acute bacterial infections. This could be due to the time required for its production or to a lack of response of ferritin to the bacterial inflammatory process. Medical records of hospitalized patients with acute hyper inflammation were retrieved and studied, looking closely at two acute phase proteins: C-reactive protein (CRP) and ferritin. The estimated time between symptom onset and the procurement of blood tests was also measured. 225 patients had a median ferritin level of 109.9 ng/mL [IQR 85.1, 131.7] and a median CRP level of 248.4 mg/L [IQR 221, 277.5]. An infectious inflammatory process was identified in 195 patients. Ferritin levels were relatively low in comparison with the CRP in each group, divided according to time from symptom onset until the procurement of blood tests. The discrepancy between high CRP and low ferritin suggests that these two acute phase response proteins utilize different pathways, resulting in a failure to increase ferritin concentrations in a documented state of hyperinflammation. A new entity of normoferremic inflammation accounts for a significant percentage of patients with acute bacterial infections, which enables bacteria to better survive the inflammation and serves as a new "inflammatory stamp".

Identifiants

pubmed: 37511109
pii: ijms241411350
doi: 10.3390/ijms241411350
pmc: PMC10379163
pii:
doi:

Substances chimiques

Acute-Phase Proteins 0
Biomarkers 0
C-Reactive Protein 9007-41-4
Ferritins 9007-73-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Clin Nutr. 2010 Dec;92(6):1406-15
pubmed: 20962160
Blood. 1977 Jan;49(1):147-53
pubmed: 830372
JCI Insight. 2021 Jul 8;6(13):
pubmed: 34236052
Int J Hematol. 2018 Jan;107(1):7-15
pubmed: 29147843
Microbiology (Reading). 1995 Aug;141 ( Pt 8):1985-1992
pubmed: 7551061
J Biol Chem. 1978 Jun 25;253(12):4451-8
pubmed: 659425
Clin Infect Dis. 2020 Dec 23;71(Suppl 4):S409-S415
pubmed: 33367576
Science. 2004 Dec 17;306(5704):2090-3
pubmed: 15514116
PLoS Pathog. 2016 Dec 15;12(12):e1005973
pubmed: 27977798
Blood. 2022 Jul 21;140(3):262-273
pubmed: 35500103
Blood. 2019 May 16;133(20):2212-2221
pubmed: 30808634
Lancet. 2013 Jul 6;382(9886):29-40
pubmed: 23602230
Clin Infect Dis. 2013 Dec;57(11):1626-34
pubmed: 23956164
Biomed Pharmacother. 2021 Oct;142:112002
pubmed: 34463264
Blood. 2002 May 1;99(9):3326-34
pubmed: 11964300
Acta Med Scand. 1979;205(7):641-5
pubmed: 382753
Am J Clin Nutr. 2015 Mar;101(3):668-79
pubmed: 25733652
Microbiol Mol Biol Rev. 2007 Sep;71(3):413-51
pubmed: 17804665
Pediatr Infect Dis J. 2012 Aug;31(8):795-8
pubmed: 22531233
Cell. 2017 Jan 26;168(3):344-361
pubmed: 28129536
J Med Microbiol. 2006 Jun;55(Pt 6):661-668
pubmed: 16687582
J Nutr Biochem. 2009 Jan;20(1):11-6
pubmed: 18495462
Lancet. 2006 Jan 14;367(9505):133-43
pubmed: 16413877
J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):262-4
pubmed: 19525869
JAMA. 1975 Jan 6;231(1):39-41
pubmed: 1243565
JAMA Netw Open. 2021 Nov 1;4(11):e2133935
pubmed: 34767026
PLoS Pathog. 2014 Feb 13;10(2):e1003935
pubmed: 24550730
J Infect Dis. 1999 Jan;179(1):275-8
pubmed: 9841854
Front Immunol. 2019 Feb 04;10:131
pubmed: 30804939
J Infect Dis. 2006 Feb 15;193(4):537-46
pubmed: 16425133
Infection. 1992;20 Suppl 4:S261-5
pubmed: 1294514
Autophagy. 2016 May 3;12(5):850-63
pubmed: 27002654
J Clin Med. 2022 Sep 16;11(18):
pubmed: 36143085
Free Radic Biol Med. 2002 Aug 15;33(4):457-63
pubmed: 12160928
J Biol Inorg Chem. 2013 Mar;18(3):371-81
pubmed: 23417538
Mol Microbiol. 2004 Aug;53(3):807-20
pubmed: 15255894
Mol Med. 2018 Aug 30;24(1):46
pubmed: 30165816
Biol Met. 1991;4(1):7-13
pubmed: 1830211
Blood. 2022 Nov 10;140(19):2011-2023
pubmed: 35994752
Physiol Rev. 1984 Jan;64(1):65-102
pubmed: 6420813
Infect Immun. 2012 Oct;80(10):3650-9
pubmed: 22802345
Immunobiology. 2014 Feb;219(2):149-57
pubmed: 24157279
Int Immunol. 2017 Nov 1;29(9):401-409
pubmed: 28541437
J Clin Lab Anal. 2020 Oct;34(10):e23618
pubmed: 33078400
EMBO J. 2003 May 1;22(9):1959-68
pubmed: 12727864

Auteurs

Tal Levinson (T)

Infectious Diseases Unit, Tel-Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel Aviv 6423906, Israel.
Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Eugene Feigin (E)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Department of Endocrinology, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Shlomo Berliner (S)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Shani Shenhar-Tsarfaty (S)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Itzhak Shapira (I)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Ori Rogowski (O)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

David Zeltzer (D)

Department of Emergency Medicine, Tel-Aviv Sourasky Medical Center, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Ilana Goldiner (I)

Clinical Laboratory Services, Tel Aviv Sourasky Medical Center, Tel Aviv, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Moshe Shtark (M)

Clinical Laboratory Services, Tel Aviv Sourasky Medical Center, Tel Aviv, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Malka Katz Shalhav (M)

Department of Emergency Medicine, Tel-Aviv Sourasky Medical Center, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Asaf Wasserman (A)

Departments of Internal Medicine C, D and E, Tel Aviv Sourasky Medical Center Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH